2016 ACMG: Risk Assessment and Quality Plans for Next-Generation Sequencing (NGS) assays in the context of evolving regulatory frameworks
Next generation sequencing (NGS) technologies enable high-throughput sequencing and play an essential role in the operational implementation of personalized or precision medicine approaches.